Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
516.00
Ask:
520.00
Spread: 4.00 (0.775%)
Market Cap: £860.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Capital Commitment

6 Jul 2020 07:00

RNS Number : 0494S
Oakley Capital Investments Limited
06 July 2020
Β 

6Β July 2020

Oakley Capital Investments Limited

Β 

Capital Commitment to Oakley Capital Origin Fund

Β 

Oakley Capital Investments Limited1Β (the "Company"),Β a listed investment vehicle providing investors access to the Oakley Funds2, is pleased to announce that at this time it has made a commitment of €75 million to the Oakley Capital Origin Fund ("The Origin Fund"), the latest Oakley Capital fund. The Origin Fund will follow the same investment strategy as the existing Oakley Funds but will focus on private companies in the lower mid-market, with enterprise values of up to €100 million. The Origin Fund's typical investment size will be between €10 million and €50 million.

- ends -

Β 

For further information please contact:

Β 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

Β 

Greenbrook Communications Limited

+44 20 7952 2000

Alex Jones / Gina Bell / James Williams

Β 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Gillian Martin / Owen Matthews

Β 

Notes:

LEI Number: 213800KW6MZUK12CQ815

1Β About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle, which provides access to the Oakley Funds2. It is a liquid vehicle that aims to provide capital growth and dividends to investors.

2 The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III and Oakley Capital IV are unlisted mid-market private equity funds with the aim of providing investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

The Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCDZGGNLKVGGZM
Date   Source Headline
23rd Dec 20257:01 amRNSTransaction in Own Shares
23rd Dec 20257:01 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSOakley Capital invests in Athena Racing
23rd Dec 20257:00 amRNSOakley Capital invests in Athena Racing
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:09 amRNSOCI to participate in Time Out equity placing
18th Dec 20257:01 amRNSTransaction in Own Shares
17th Dec 20257:01 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSOakley Capital invests in James Perse
16th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:01 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSOakley Capital invests in Paraty Tech
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSDirector Dealing
3rd Nov 20257:01 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:01 amRNSAppointment of Chair Designate and NED
29th Oct 20257:00 amRNSQ3 Trading Update and Board Appointments
28th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSOakley Capital agrees sale of atHome
15th Oct 20257:01 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSOakley Capital invests in premium padel brand NOX
14th Oct 20257:00 amRNSOakley Capital invests in ONHC
1st Oct 20257:00 amRNSTotal Voting Rights
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20255:23 pmRNSDirector Dealing
16th Sep 20257:00 amRNSOakley renews commitment to K12 investments
11th Sep 20257:00 amRNSInterim Results for the 6 months ended 30 June 25
10th Sep 20257:00 amRNSResult of AGM - Replacement
2nd Sep 20252:20 pmRNSResult of AGM
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 202512:45 pmRNS-RQuotedData's In The HotSeat Special
28th Aug 20257:00 amRNSNotice of Results and Investor Presentation
21st Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSDirector Dealing
7th Aug 20257:00 amRNSNotice of Annual General Meeting
4th Aug 20257:00 amRNSOakley granted exclusivity to invest in Brevo

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.